
Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …

Michael Connellan, Head of External Affairs at the type 1 diabetes charity JDRF, discusses the results of a recent survey …

Mike Elliott, Vice President of Medical Affairs at Gilead (pictured, right), chats about the company’s sponsorship of a ‘A life …

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …

Speaking to Pharmafocus , David Nicholson, Chief R&D Officer at Allergan, revealed that the company has big plans in the …

After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …

Pharmafocus spoke to Dr Harald Nusser, Head of Novartis Social Business, and David Reddy, CEO of Medicines for Malaria Venture …

Paul Catchpole, Value and Access Director at the Association of the British Pharmaceutical Industry (ABPI), gives his thoughts on the …